Zachary Parker’s bill blocks insurers from limiting coverage to a single HIV prevention drug and protects access to PrEP and PEP.
An HRC survey finds declining acceptance, growing insecurity, and widening barriers to work, food, and health care for LGBTQ Americans.
A study suggests twice-yearly Yeztugo offers HIV prevention without adversely affecting gender-affirming care.
Grindr’s in-house sex expert discusses the app’s top "tags," LGBTQ identities, and evolving user behavior beyond hookups.
HHS cancels California’s $12M sex ed grant and warns 46 states to strip gender identity from curricula or risk losing federal funding.
CVS refused to cover Yeztugo, Gilead’s $28,000-a-year injectable PrEP, preventing patients from accessing the HIV prevention drug at no cost.
Scientific breakthroughs take center stage at the International AIDS Society Conference as global HIV funding and political support erode.
The U.S. Supreme Court has upheld the constitutionality of the U.S. Preventive Services Task Force, saving free PrEP and other preventive treatments, including screenings for...
The telehealth platform MISTR reports that its efforts to connect patients with DoxyPEP has led to a more than 50% drop in STI diagnoses.
Christian employers challenged the constitutionality of provisions in the Affordable Care Act requiring coverage for preventative services.
From oral PrEP, to injectables, rings, and implants, this year's HIV Research for Prevention conference was all about options.
A recent study has found that lenacapavir, an injectable medication administered twice a year, is more effective at preventing HIV among gay, bisexual, and transgender...
TikTok creator and fashion influencer Zach Willmore raises his voice as an advocate for young people living with HIV.
The International AIDS Conference in Munich, Germany was buzzing with the promise of hope for a viable cure.
The CDC issues national guidelines for use of Doxy-PEP to prevent STIs, amidst alarming rise in infection rates.